News

EST on Bloomberg Television NEW YORK CITY, NY / ACCESS Newswire / July 12, 2025 / New to The Street, the leading ...
US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...
A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
All Pro Overhead Garage Doors, a top garage door service with more than 20 years in the business, is putting more focus on ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...